Lucid Diagnostics (LUCD) Balance Sheet: Assets & Liabilities

Lucid Diagnostics (LUCD) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Lucid Diagnostics reported total assets of $40.45M and total liabilities of $29.51M. Shareholders' equity was $10.94M, up 102.9% from $5.39M a year earlier. Total debt stood at $24.93M against $34.70M in cash and short-term investments, a net cash position of $9.78M. That puts debt-to-equity at 2.28, compared with 3.78 a year earlier.

Lucid Diagnostics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Lucid Diagnostics Inc. (LUCD) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	34.71	22.36	18.90	22.47	53.66	0.11	0.16	0.02
Short-Term Investments	0.99	1.02	0.00	0.00	1.12	0.12	0.00	0.00
Cash & Short-Term Investments	34.71	23.38	18.90	22.47	54.77	0.23	0.16	0.02
Accounts Receivable	0.64	0.05	0.05	0.02	0.20	0.00	0.00	0.00
Inventory	0.35	0.34	0.28	0.11	0.49	0.83	0.00	0.00
Other Current Assets	1.77	2.40	2.85	1.75	3.45	0.50	0.23	0.00
Total Current Assets	37.47	25.15	22.07	24.36	57.30	1.44	0.39	0.02
Non-Current Assets
Property, Plant & Equipment (Net)	2.62	3.70	2.64	3.60	0.97	0.00	0.00	0.00
Intangible Assets	0.32	0.74	1.42	3.45	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.05	1.13	1.13	1.11	0.73	0.76	0.64	0.00
Total Non-Current Assets	2.98	5.57	5.20	8.15	1.70	0.76	0.64	0.00
Total Assets	40.45	30.72	27.27	32.51	59.00	2.20	1.03	0.02
Current Liabilities
Accounts Payable	0.97	1.24	1.15	1.06	1.49	2.06	0.80	0.50
Short-Term Debt	24.00	18.60	15.06	0.96	0.00	0.00	0.00	0.00
Accrued Liabilities	0.68	2.83	3.84	1.45	1.11	3.07	-	-
Deferred Revenue	0.00	0.00	0.94	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	0.40	0.42	12.24	6.41	1.66	10.58	5.54	0.58
Total Current Liabilities	28.58	23.52	29.38	8.43	4.26	15.71	6.34	1.08
Non-Current Liabilities
Long-Term Debt	0.93	1.80	0.20	1.04	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.93	1.80	0.20	1.04	0.00	0.00	0.00	0.00
Total Liabilities	29.51	25.32	29.58	9.46	4.26	15.71	6.34	1.08
Stockholders' Equity
Common Stock	0.13	0.06	0.04	0.04	0.04	0.01	0.01	0.01
Retained Earnings	-274.34	-203.77	-150.74	-98.08	-41.90	-13.83	-5.55	-1.13
Additional Paid-in Capital	230.87	154.68	129.76	121.08	96.61	0.29	0.22	0.05
Shares Outstanding	131.10	63.07	42.33	40.52	34.92	-	-	-
Total Stockholders' Equity	10.94	5.39	-2.31	23.05	54.74	-13.52	-5.31	-1.06
Total Liabilities & Equity	40.45	30.72	27.27	32.51	59.00	2.20	1.03	0.02

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Lucid Diagnostics Balance Sheet

How much debt does Lucid Diagnostics have?

Lucid Diagnostics had total debt of $24.93M as of Dec 31, 2025, against $34.70M in cash and short-term investments. Its debt-to-equity ratio was 2.28. Total debt was $20.40M a year earlier.

What are Lucid Diagnostics's total assets?

Lucid Diagnostics reported total assets of $40.45M as of Dec 31, 2025, up 31.7% from $30.71M a year earlier. Total liabilities were $29.51M.

What is Lucid Diagnostics's shareholders' equity?

Lucid Diagnostics's shareholders' equity was $10.94M as of Dec 31, 2025, or about $0.08 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition